These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 42510)

  • 1. Comparison of the speed of bronchodilator action after inhaled fenoterol and rimiterol in reversible airways obstruction.
    Vanderschueren RG; Van Bever RJ; Laros CD; Swierenga J
    Curr Med Res Opin; 1979; 6(3):183-92. PubMed ID: 42510
    [No Abstract]   [Full Text] [Related]  

  • 2. A three month study of the bronchodilator effects of aerosolized fenoterol and isoproterenol.
    Beall GN; Steen SN; Kuo J; Smith R
    Chest; 1978 Jun; 73(6 Suppl):996-7. PubMed ID: 354893
    [No Abstract]   [Full Text] [Related]  

  • 3. [Double blind trial of hexoprenaline as a bronchodilator].
    Ulmer WT
    Arzneimittelforschung; 1974 May; 24(5):840-1. PubMed ID: 4603484
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of cardiorespiratory effects of rimiterol and terbutaline aerosols.
    Harris L
    Bull Physiopathol Respir (Nancy); 1974; 10(6):801-10. PubMed ID: 4156915
    [No Abstract]   [Full Text] [Related]  

  • 5. The bronchodilator effect of fenoterol (Berotec).
    Powles AC
    N Z Med J; 1975 Mar; 81(535):249-51. PubMed ID: 1055321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of combined oral theophylline and inhaled beta-adrenoceptor agonist bronchodilator therapy.
    Marlin GE; Hartnett BJ; Berend N; Hacket NB
    Br J Clin Pharmacol; 1978 Jan; 5(1):45-50. PubMed ID: 23134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerosol administration of fenoterol hydrobromide (Th 1165a) in subjects with reversible obstructive airway disease.
    Pennock BE; Rogers RM; Ryan BR; Ayers LN
    Chest; 1977 Dec; 72(6):731-6. PubMed ID: 336306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchodilator effects of nebulized fenoterol: a comparison with isoproterenol.
    Watanabe S; Turner WG; Renzetti AD; Harless KW; Bigler AH; Cutillo A
    Chest; 1981 Sep; 80(3):292-9. PubMed ID: 7023862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical testing of bronchospasmolytics in combined alternating test schedules].
    Kaik G
    Int J Clin Pharmacol Biopharm; 1976 Mar; 13(2):97-106. PubMed ID: 3472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined administration of ipratropium bromide (sch 1000) and fenoterol in patients with chronic obstructive airway disease (author's transl)].
    Kaik G
    Wien Klin Wochenschr; 1975 Oct; 87(19):653-6. PubMed ID: 132015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the bronchodilatory action of two drugs.
    Prime FJ; Kamburoff PL; Günthner W
    Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):293-6. PubMed ID: 4402115
    [No Abstract]   [Full Text] [Related]  

  • 12. Fenoterol: clinical trial of a new long acting bronchodilator.
    Emirgil C; Palmer K; VanVoorhies L; Wesson C; Sobol BJ
    Ann Allergy; 1977 Dec; 39(6):415-7. PubMed ID: 339786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the effects of salbutamol, fenoterol, and placebo aerosols on airway resistance in asthmatics.
    Siddorn JA
    Med J Zambia; 1976 Dec-1977 Jan; 10(6):153-6. PubMed ID: 14454
    [No Abstract]   [Full Text] [Related]  

  • 14. The efficacy of terbutaline and fenoterol aerosols on adult exercise-induced asthma [proceedings].
    Tammivaara R
    Scand J Respir Dis Suppl; 1979; 103():212-3. PubMed ID: 373092
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of ipratropium bromide and fenoterol on airway obstruction in chronic pulmonary tuberculosis.
    Salorinne Y; Stenius-Aarniala B; Poppius H
    Respiration; 1979; 38(3):151-4. PubMed ID: 160068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind trial with increasing doses of salbutamol and terbutaline aerosols in patients with reversible airways obstruction.
    Simonsson BG; Stiksa J; Ström B
    Acta Med Scand; 1972 Nov; 192(5):371-6. PubMed ID: 4563324
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of lung function indices for bronchodilator trials. Results of a cross-over study of fenoterol.
    Stănescu D; van Lemputten R; Frans A; Brasseur L
    Respiration; 1976; 33(1):1-8. PubMed ID: 1105725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The oral application of berotec in the therapy of obstructive airway diseases].
    Veres R
    Fortschr Med; 1978 Mar; 96(10):553-7. PubMed ID: 631690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of the bronchospasmolytic effect of fenoterol (0.2 mg) salbutamol (0.4 mg) as powder inhalations in 20 patients with reversible bronchial obstruction.
    Maesen FP; Smeets JJ; Bernsen R; Cornelissen PJ
    Respiration; 1984; 45(3):265-70. PubMed ID: 6379788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fenoterol suppositories in obstructive respiratory diseases].
    Krieger E
    Ther Ggw; 1979 Jun; 118(6):970-4. PubMed ID: 380048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.